Dr. Maciej Kosakowski is a Feasterville Trevose, Pennsylvania based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. Maciej Kosakowski is DS044537 for Oral and Maxillofacial Surgery in Pennsylvania. His current practice location is 1300 Bridgetown Pike, Feasterville Trevose. Patients can reach him at 215-322-7810.
Dr. Maciej Kosakowski deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Maciej Kosakowski speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1467085498
NPI Enumeration Date:
18 Feb, 2020
NPI Last Update On:
09 May, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Maciej Kosakowski are as mentioned below.
License Number
Specialization
State
Status
DS044537
Oral and Maxillofacial Surgery
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
435 E 70th St Apt 31a, New York, New York
Zip:
10021-5350
Patients can reach Dr. Maciej Kosakowski at 1300 Bridgetown Pike, Feasterville Trevose, Pennsylvania or can call to book an appointment on 215-322-7810. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.